Argos Therapeutics, Inc.
BISPECIFIC ANTIBODIES THAT MODULATE TLR-4 SIGNALING AND USES THEREOF

Abstract:

Antibodies are provided that alter the TLR4 signaling pathway to produce an immunosuppressive effect. The antibodies are useful for the treatment or prevention of an unwanted immune response in a subject, such as autoimmune disease, transplant rejection, and allergic reactions.